MassDevice20h
Spineart, eCential Robotics earn FDA nod for robotic-assisted spine surgery application
Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic ...
Becker's Spine Review17h
Spineart, eCential Robotic earn FDA accreditation for spine surgery robot
The FDA has cleared Spineart’s Perla TL application for use with eCential Robotics Op.nTM robotic navigation platform. The clearance will combine Spineart and eCential Robotics’ robotic-assisted spine ...
Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platform
FOR IMMEDIATE RELEASE Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic ...
Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiority
Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiorityGeneva, March 11, 2025 – Spineart, a fast-growing company in ...
Becker's Spine Review2d
Baguera-C disc meets non-inferiority threshold in ongoing IDE study
Interim data on Spineart’s Baguera-C cervical disc shows the device meets the threshold for a non-inferiority claim compared to a study control, the medtech company said March 11. Spineart plans to ...
Morningstar3d
Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiority
Geneva, March 11, 2025 – Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 1-level BAGUERA®C IDE study ...
manilatimes3d
Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiority
Geneva, March 11, 2025 - Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 1-level BAGUERA®C IDE study, which ...